This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Brigham Young University, University of Alberta. Active years: 1991-2013.
Company Filing History:
Years Active: 1991-2013
Title: Morris J Robins: Innovator in Purine Nucleoside Chemistry
Introduction
Morris J Robins is a notable inventor based in Provo, UT (US), recognized for his contributions to the field of purine nucleoside chemistry. He holds a total of 5 patents, showcasing his innovative approaches to drug development and synthesis.
Latest Patents
Robins' latest patents include a method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine. This invention focuses on a method for preparing 2-halo-6-aminopurines, particularly the clinical agent cladribine, which is used in the treatment of hairy-cell leukemia and other neoplasms. The process involves converting the 6-oxo group of a protected 2'-deoxyguanosine into a leaving group, followed by a series of substitutions to yield the desired 6-amino group. Another significant patent describes methods for selective N-9 glycosylation of purines, allowing for the regiospecific and highly stereoselective synthesis of 9-β anomeric purine nucleoside analogs. This process ensures high yields without the formation of unwanted regioisomers.
Career Highlights
Throughout his career, Robins has made significant strides in the pharmaceutical field, particularly in the synthesis of nucleoside analogs. His work has contributed to the development of drugs that serve as vital therapeutic agents.
Collaborations
Morris J Robins has collaborated with notable institutions such as Brigham Young University and the University of Alberta. He has also worked alongside colleagues like Paula Francom and Zlatko Janeba, contributing to various research projects and innovations.
Conclusion
Morris J Robins stands out as a key figure in the realm of purine nucleoside chemistry, with a focus on developing methods that enhance drug synthesis and efficacy. His innovative patents and collaborations reflect his commitment to advancing medical science.